Paragon 28, Inc.

announced
FNASEC EDGARCIK: 0001531978|Medical Technology

Capital Structure & Economics

Trust SizeN/A
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Public Trust AllocationN/A
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedSep 24, 2021
Target AnnouncedJan 28, 2025
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyZimmer Biomet Holdings, Inc.
  • SectorMedical Technology
  • Announcement Date2025-01-28

Board & Officers

  • Albert DaCostaCEO
  • Quentin BlackfordDirector
  • Dave DemskiDirector
  • Alf GrunwaldDirector
  • B. Kristine JohnsonDirector
  • Stephen Oesterle, M.D.Director
  • Meghan ScanlonDirector
  • Thomas SchnettlerDirector
  • Kristina WrightDirector
  • Scott DrakeDirector

Advanced Structuring Terms

Target SectorsMedical Technology

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.